H.I.G. Capital’s Acquisition of Aspire Pharma

Baker McKenzie advised H.I.G. Capital on the transaction.H.I.G. Capital, a leading global alternative investment firm with $45 billion of equity capital under management, announced that one…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Alejandro Girola

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here